Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 433-730-7 | CAS number: 23926-51-4 L-THREONINETHYLESTER
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Genetic toxicity in vitro
Link to relevant study records
- Endpoint:
- in vitro gene mutation study in bacteria
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- March 31, 2000 - April 19, 2000
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: The study was performed in compliance with GLP standards.
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- other: Annex V of Directive 92/69/EEC (1993). B14 Mutagenicity Reverse Mutation Assays.
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- other: UKEMS Guidelines (1990)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- other: ICH Harmonised Tripartite Guideline (1997)
- Deviations:
- no
- Principles of method if other than guideline:
- NA
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- bacterial reverse mutation assay
- Target gene:
- Strain Type of mutation in the histidine gene
TA 98 frame-shift
TA100 base-pair substitution
TA1535 base-pair substitution
TA1537 frame-shift
TA102 base-par substitution - Species / strain / cell type:
- S. typhimurium TA 1535, TA 1537, TA 98, TA 100 and TA 102
- Details on mammalian cell type (if applicable):
- NA
- Additional strain / cell type characteristics:
- not specified
- Metabolic activation:
- with and without
- Metabolic activation system:
- Liver post-mitochondrial fraction (S-9) prepared from male Sprague Dawley rats induced with Aroclor 1254
- Test concentrations with justification for top dose:
- Concentration range in the range-finder experiment and mutation experiment (with and without metabolic activation): 1.6, 8, 40, 200, 1000 and 5000 µg/plate
Concentration range in Mutation experiment 2 (with and without metabolic activation): 156.25, 312.5, 625, 1250, 2500 and 5000 µg/plate . - Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: DMSO
- Justification for choice of solvent/vehicle: solubility - Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- Remarks:
- DMSO
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- 2-nitrofluorene
- Remarks:
- 2-nitrofluorene was used without S9-mix at the following concentration: 5.0 µg/plate (TA98).
- Positive controls:
- yes
- Positive control substance:
- sodium azide
- Remarks:
- Sodium azide was used without S9-mix at the following concentration: 2.0 µg/plate (TA100, TA1535).
- Positive controls:
- yes
- Positive control substance:
- 9-aminoacridine
- Remarks:
- 9-aminoacridine was used without S9-mix at the following concentration: 50.0 µg/plate (TA1537).
- Positive controls:
- yes
- Positive control substance:
- other: glutaraldehyde
- Remarks:
- Glutaraldehyde was used without S9-mix at the following concentration: 25.0 µg/plate (TA102).
- Positive controls:
- yes
- Positive control substance:
- benzo(a)pyrene
- Remarks:
- Benzo[a]pyrene was used with S9-mix at the following concentration: 10.0 µg/plate (TA98).
- Positive controls:
- yes
- Positive control substance:
- other: 2-aminoanthracene
- Remarks:
- 2-aminoanthracene was used with S9-mix at the following concentrations: 5.0 µg/plate (TA100, TA1535, TA1537) and 20.0 µg/plate (TA102).
- Details on test system and experimental conditions:
- METHOD OF APPLICATION:; direct plate incorporation method, and the preincubation method
DURATION
- Preincubation period: none in range-finder experiment and mutation experiment 1, 1 hour in the mutation experiment 2.
- Exposure duration: 3 days
- Expression time (cells in growth medium): NA
- Selection time (if incubation with a selection agent): NA
- Fixation time (start of exposure up to fixation or harvest of cells): NA
SELECTION AGENT (mutation assays): No data
NUMBER OF REPLICATIONS: triplicate plates
NUMBER OF CELLS EVALUATED: no data
DETERMINATION OF CYTOTOXICITY
- Method: inspection of background bacterial lawn of the plates
OTHER EXAMINATIONS:
- Determination of polyploidy: NA
- Determination of endoreplication: NA
- Other: NA - Evaluation criteria:
- Acceptance criteria:
1. the mean negative control counts fell within normal ranges
2. the positive control chemicals induced clear increases in revertant numbers confirming discrimination between different strains, and an active S-9 preparation.
3. no more than 5% of the plates were list through contamination or some other unforeseen event.
Evaluation criteria:
The test article was considered mutagenic if:
1. the assay was valid (see above)
2. Dunnett's test gave a significant response (p≤0.01) and the data set(s) showed a significant dose correlation
3. the positive responses described above were reproducible - Statistics:
- The m-statistic was calculated to check that the data were Poisson-distributed, and Dunnett's test was used to compare the counts of each dose with control. The presence or ortherwise of a dose-response was checked by linear regression analysis.
- Species / strain:
- S. typhimurium TA 1535, TA 1537, TA 98, TA 100 and TA 102
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Additional information on results:
- TEST-SPECIFIC CONFOUNDING FACTORS
- Effects of pH: no data
- Effects of osmolality: no data
- Evaporation from medium: no data
- Water solubility: L-TEE was completely soluble in the aqueous assay system at all concentrations treated in each of the experiments performed.
- Precipitation: No precipitation was observed
RANGE-FINDING/SCREENING STUDIES: a range-finder experiment was performed.
COMPARISON WITH HISTORICAL CONTROL DATA: The solvent control and the positive controls were acceptable and fell within the normal historical ranges.
ADDITIONAL INFORMATION ON CYTOTOXICITY: No cytotoxicity was observed at any concentration. - Conclusions:
- L-TEE was tested for mutation in five histine-required strains of Salmonella typhimurium, both in the absence and in the presence of metabolic activation S-9. All the test strains were tested at concentrations up to 5000 µg/plate as the maximum test dose. It was concluded that L-TEE did not induce mutation in five strains of Salmonella typhimurium (TA98, TA100, TA1535, TA1537 and TA102), when tested under the conditions employed in this study.
- Executive summary:
L-TEE was tested for mutation in five histidine-required strains of Salmonella typhimurium, both in the absence and in the presence of metabolic activation S-9. All the test strains were tested at concentrations up to 5000 µg/plate as the maximum test dose.
The mean number of revertant colonies on negative control plates all fell within acceptable ranges, and were significantly elevated by positive control treatments. No L-TEE treatments of the test strains resulted in increased revertant numbers that could be considered indicative of any test article mutagenic activity. No signs of toxicity were apparent for any of the test plates, either with or without S-9.
It was concluded that L-TEE did not induce mutation in five strains of Salmonella typhimurium (TA98, TA100, TA1535, TA1537 and TA102), when tested under the conditions employed in this study.
Reference
None
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (negative)
Genetic toxicity in vivo
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
Additional information from genetic toxicity in vitro:
L-TEE was tested for
mutation in five histidine-required strains of Salmonella typhimurium,
both in the absence and in the presence of metabolic activation S-9. All
the test strains were tested at concentrations up to 5000µg/plate as the
maximum test dose. It was concluded that L-TEE did not induce mutation
in five strains of Salmonella typhimurium (TA98, TA100, TA1535, TA1537
and TA102), when tested under the conditions employed in this study
(OECD 471).
L-TEE was tested in an in vitro cytogenetics assay using cultured human peripheral blood lymphocytes in both the absence and presence of a rat liver metabolic activation system (S-9). L-TEE was tested up to 10 mM, an acceptable maximum concentration for in vitro chromosome aberration studies according to current regulatory guidelines (OECD 473). L-TEE did not induce chromosome aberrations.
L-TEE was tested for mutagenic potential in an in vitro mammalian cell mutation assay using mouse lymphoma L5178Y cells in accordance with OECD 476. L-TEE did not demonstrate mutagenic potential in the in vitro cell mutation assay using mouse lymphoma L5178 cells, hence L-TEE was found to be non-mutagenic.
Justification for classification or non-classification
In summary, L-TEE was shown not to have genotoxic properties in the reverse mutation assay (Ames Test) or in the in vitro assays, cytogenetics assay and cell mutation assay. Based on these results, it is concluded that L-TEE is not genotoxic and not classified according to CLP or DSD for this endpoint.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.